Clinico-hematological profile and outcome of acute promyelocytic leukemia patients at a tertiary care center in North India

Abstract

Our data reflects that APL remains a highly curable malignancy with good response to ATRA plus anthracycline based chemotherapy even with a greater number of high and intermediate risk patients. Only DIC during induction chemotherapy bore an impact on survival in our patients.